European countries pay less than the U.S. because they negotiate & set basic disciplines on the prices that drug monopolists can charge.
— Peter Maybarduk (@Maybarduk) September 13, 2020
Also, if you are serious about lowering drug why wait 3.5 years to do this? It’s too little too late, especially when you realize the President still opposes HR3, passed by House in December. https://t.co/2dDxAd0R3C
— Lower Drug Prices Now (@peopleb4pharma) September 13, 2020